Skip to content
VLOCMarket desk
Switch to dark mode

텔콘RF제약

200230KOSDAQView the 제약 sectorTheme Bio & healthcare

2,150KRWMarket close of 10/27 (Tue)

Up +4.12%+85KRWMarket close of 10/27 (Tue)

Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)2,080KRWDown -3.26%

Preliminary · replaced once official KRX data for the same date is published

Open
2,040
High
2,150
Low
2,025
Day range
Day range low 2,025 high 2,150, open 2,040, close 2,150, previous close 2,065
Volume
3×10K shares
59.41 million KRW 1.40× the 20-session average

Market close of 10/27 (Tue)

Usual range

Nothing unusual in the 4 checked items

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27

Points to check

  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
  • Daily moveusual range+4.12%+4.12%, 1.9× the usual (20-session average ±2.19%)
    That day +4.12% · usual ±2.19% · large-move threshold ±4.4%

The other 2 are within the usual range

  • Trading value1.4×usual range
  • EarningsOperating income, 8 quartersOperating income, 8 quarters

With 79 trading days, the 1-year position isn't calculated · First data date 6/30 (Tue)

See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue9.7B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -2.8%
    vs. prior quarter
    -27.2%
  • Operating income-1.4B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Still a loss
    vs. prior quarter
    Turned to loss
  • Operating margin-14.7%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +0.3 pp
    vs. prior quarter
    -34.4 pp

Quarterly operating income trend

As of the latest official close · 2026-10-27Valuation filing date · 2026-05-15
2021Q1 -1.6B KRW2026Q1 -1.4B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Down -2.22%

· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +0.6%Down -5.37%124.5B KRW
셀트리온Close over the last 20 sessions +6.3%Down -0.74%82.4B KRW
지투지바이오Close over the last 20 sessions +22.2%Down -13.38%46.9B KRW
한미약품Close over the last 20 sessions -32.6%Down -0.57%25.5B KRW
에스티팜Close over the last 20 sessions -11.9%Down -9.15%21.4B KRW

Schedule

  • Next data 10/29 (Thu) after 08:50

Related news

All news
Loading

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.